Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23664987 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed MVA Post-Event: Administration Timing and Boost Study
Condition: Smallpox
Interventions: Drug: Placebo (subcutaneous);   Drug: Placebo (scarification);   Biological: Dryvax®;   Biological: IMVAMUNE®

Indicates status has not been verified in more than two years